Venture
K Health, Inc.
Latest Form D 2026-08-19- CIK 1689694
- State NY
- Other Technology
- 10 Form D offerings since 2016-11-21
- Total sold
- $412M
- across 10 offerings
- Rounds
- 10
- Form D offerings since 2016-11-21
- Latest round
- $58.9M
- 2026-08-19 · 021-594698
- Investors
- 19
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-08-19 · $58.9M
- 2016-11-21$3.1M021-274902
- 2017-06-13$3.2M021-288602
- 2018-01-30$5.1M021-304363
- 2018-12-19$25M021-328468
- 2019-07-23$12M021-344851
- 2020-03-05$47.9M021-362050
- 2020-11-19$36.7M021-381019
- 2021-01-19$132M021-386720
- 2024-07-24$88.4M021-519647
- 2026-08-19$58.9M021-594698
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($132M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-594698 | First filed2026-08-19 | Latest2026-08-19 | Sought$68.9M | Sold$58.9M | Investors19 | Exemptions506(b) |
| 021-519647 | First filed2024-07-24 | Latest2024-07-24 | Sought$134M | Sold$88.4M | Investors26 | Exemptions506(b) |
| 021-386720 | First filed2021-01-19 | Latest2021-01-19 | Sought$132M | Sold$132M | Investors16 | Exemptions506(b) |
| 021-381019 | First filed2020-11-19 | Latest2020-11-19 | Sought$36.7M | Sold$36.7M | Investors9 | Exemptions506(b) |
| 021-362050 | First filed2020-03-05 | Latest2020-03-05 | Sought$50M | Sold$47.9M | Investors21 | Exemptions506(b) |
| 021-344851 | First filed2019-07-23 | Latest2019-07-23 | SoughtIndefinite | Sold$12M | Investors1 | Exemptions506(b) |
| 021-328468 | First filed2018-12-19 | Latest2018-12-19 | Sought$25M | Sold$25M | Investors15 | Exemptions506(b) |
| 021-304363 | First filed2018-01-30 | Latest2018-01-30 | Sought$5.6M | Sold$5.1M | Investors10 | Exemptions506(b) |
| 021-288602 | First filed2017-06-13 | Latest2017-06-13 | Sought$3.2M | Sold$3.2M | Investors7 | Exemptions506(b) |
| 021-274902 | First filed2016-11-21 | Latest2016-11-21 | Sought$3.3M | Sold$3.1M | Investors11 | Exemptions506(b) |
Who backs K Health, Inc. — 3 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-08-19
| Name | Relationship |
|---|---|
| Allon Bloch | RelationshipExecutive Officer, Director |
| Adam Singolda | RelationshipDirector |
| Mark Tluszcz | RelationshipDirector |
| Alejandro Zubillaga | RelationshipDirector |
| Vivek Pattipati | RelationshipDirector |
| Saad Ehtisham | RelationshipDirector |
| Vivian Riefberg | RelationshipDirector |
| Niyum Gandhi | RelationshipDirector |
| C. Okey Agba | RelationshipDirector |
| Nir Zohar | RelationshipDirector |
| Chen Yehudai | RelationshipExecutive Officer |
| Yaron Savoray | RelationshipExecutive Officer |
| Ran Shaul | RelationshipExecutive Officer |
| Zac Siegel | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Other Technology
- State
- New York (NY)
- Exemptions
- Rule 506(b)
- First filed
- 2016-11-21
- Latest filing
- 2026-08-19
Who backs K Health, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗